Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Zilretta™, Flexion’s non-opioid lead drug candidate (also known as FX006), completed pivotal Phase 2b ...
Two clinical studies published in peer-reviewed journals validate continued accuracy improvements of the company’s ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email